Wenbin  Jiang net worth and biography

Wenbin Jiang Biography and Net Worth

Wenbin Jiang, Ph.D. has served as the Chief Executive Officer and a member of our board of directors since December 2014. Dr. Jiang is also a co-founder of our company. In 1998, Dr. Jiang co-founded E2O Communications, Inc., a fiber optic subsystems manufacturing company, which was acquired by JDS Uniphase Corporation in 2004.

Dr. Jiang is an inventor of more than 95 U.S. patents and an author of five book chapters and over 50 peer-reviewed technical papers. Dr. Jiang holds a B.S. in Physics and M.S. in Optics & Laser Physics from Fudan University and a Ph.D. in Electrical Engineering from University of California, Santa Barbara.

What is Wenbin Jiang's net worth?

The estimated net worth of Wenbin Jiang is at least $33.34 million as of November 7th, 2023. Dr. Jiang owns 5,275,796 shares of Cytek Biosciences stock worth more than $33,343,031 as of December 21st. This net worth evaluation does not reflect any other investments that Dr. Jiang may own. Additionally, Dr. Jiang receives an annual salary of $964,210.00 as CEO at Cytek Biosciences. Learn More about Wenbin Jiang's net worth.

How old is Wenbin Jiang?

Dr. Jiang is currently 60 years old. There are 6 older executives and no younger executives at Cytek Biosciences. Learn More on Wenbin Jiang's age.

What is Wenbin Jiang's salary?

As the CEO of Cytek Biosciences, Inc., Dr. Jiang earns $964,210.00 per year. Learn More on Wenbin Jiang's salary.

How do I contact Wenbin Jiang?

The corporate mailing address for Dr. Jiang and other Cytek Biosciences executives is , , . Cytek Biosciences can also be reached via phone at 877-922-9835 and via email at [email protected]. Learn More on Wenbin Jiang's contact information.

Has Wenbin Jiang been buying or selling shares of Cytek Biosciences?

Wenbin Jiang has not been actively trading shares of Cytek Biosciences during the last quarter. Most recently, Wenbin Jiang sold 20,000 shares of the business's stock in a transaction on Tuesday, November 7th. The shares were sold at an average price of $4.34, for a transaction totalling $86,800.00. Following the completion of the sale, the chief executive officer now directly owns 5,275,796 shares of the company's stock, valued at $22,896,954.64. Learn More on Wenbin Jiang's trading history.

Who are Cytek Biosciences' active insiders?

Cytek Biosciences' insider roster includes Wenbin Jiang (CEO), and Ming Yan (CTO). Learn More on Cytek Biosciences' active insiders.

Are insiders buying or selling shares of Cytek Biosciences?

During the last year, insiders at the sold shares 4 times. They sold a total of 44,900 shares worth more than $294,600.00. The most recent insider tranaction occured on April, 19th when CTO Ming Yan sold 20,000 shares worth more than $117,400.00. Insiders at Cytek Biosciences own 9.6% of the company. Learn More about insider trades at Cytek Biosciences.

Information on this page was last updated on 4/19/2024.

Wenbin Jiang Insider Trading History at Cytek Biosciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/7/2023Sell20,000$4.34$86,800.005,275,796View SEC Filing Icon  
10/9/2023Sell20,000$5.33$106,600.005,295,796View SEC Filing Icon  
9/7/2023Sell20,000$6.83$136,600.007,605,796View SEC Filing Icon  
8/7/2023Sell20,000$9.04$180,800.007,613,467View SEC Filing Icon  
7/7/2023Sell20,000$8.48$169,600.007,633,467View SEC Filing Icon  
6/7/2023Sell20,000$8.23$164,600.007,653,467View SEC Filing Icon  
5/8/2023Sell20,000$11.55$231,000.007,664,439View SEC Filing Icon  
4/10/2023Sell20,000$8.88$177,600.007,684,439View SEC Filing Icon  
3/7/2023Sell20,000$10.13$202,600.007,704,439View SEC Filing Icon  
2/7/2023Sell20,000$13.19$263,800.007,720,314View SEC Filing Icon  
1/9/2023Sell20,000$10.66$213,200.007,740,314View SEC Filing Icon  
12/7/2022Sell20,000$11.86$237,200.007,760,314View SEC Filing Icon  
11/7/2022Sell20,000$14.76$295,200.007,785,820View SEC Filing Icon  
10/7/2022Sell20,000$14.79$295,800.007,805,820View SEC Filing Icon  
9/7/2022Sell20,000$12.89$257,800.007,825,820View SEC Filing Icon  
8/8/2022Sell20,000$15.09$301,800.007,841,541View SEC Filing Icon  
7/7/2022Sell20,000$11.19$223,800.007,861,541View SEC Filing Icon  
6/7/2022Sell20,000$10.75$215,000.007,881,541View SEC Filing Icon  
5/9/2022Sell20,000$8.01$160,200.007,896,040View SEC Filing Icon  
4/7/2022Sell20,000$10.54$210,800.007,916,040View SEC Filing Icon  
3/7/2022Sell20,000$12.65$253,000.00View SEC Filing Icon  
2/7/2022Sell20,000$14.40$288,000.00View SEC Filing Icon  
See Full Table

Wenbin Jiang Buying and Selling Activity at Cytek Biosciences

This chart shows Wenbin Jiang's buying and selling at Cytek Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cytek Biosciences Company Overview

Cytek Biosciences logo
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Read More

Today's Range

Now: $6.32
Low: $6.04
High: $6.39

50 Day Range

MA: $6.06
Low: $4.69
High: $7.40

2 Week Range

Now: $6.32
Low: $4.66
High: $9.87

Volume

2,028,591 shs

Average Volume

691,686 shs

Market Capitalization

$814.09 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.46